Next Article in Journal
Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice
Next Article in Special Issue
Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
Previous Article in Journal
Nanotechnology as a Versatile Tool for 19F-MRI Agent’s Formulation: A Glimpse into the Use of Perfluorinated and Fluorinated Compounds in Nanoparticles
Previous Article in Special Issue
Long-Term Stability Prediction for Developability Assessment of Biopharmaceutics Using Advanced Kinetic Modeling
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(2), 383; https://doi.org/10.3390/pharmaceutics14020383
Action Date Notes Link
article pdf uploaded. 9 February 2022 14:27 CET Version of Record https://www.mdpi.com/1999-4923/14/2/383/pdf-vor
article xml file uploaded 21 February 2022 04:49 CET Original file -
article xml uploaded. 21 February 2022 04:49 CET Update https://www.mdpi.com/1999-4923/14/2/383/xml
article pdf uploaded. 21 February 2022 04:49 CET Updated version of record https://www.mdpi.com/1999-4923/14/2/383/pdf
article html file updated 21 February 2022 04:51 CET Original file -
article html file updated 31 July 2022 13:24 CEST Update https://www.mdpi.com/1999-4923/14/2/383/html
Back to TopTop